Skip to main content
European Commission logo
Enterprise Europe Network

Polish university spin-off offers a novel probiotic feed additive for poultry to combat Campylobacter and seeks licensing, commercial and R&D partnerships.

Summary

Profile Type
  • Technology offer
POD Reference
TOPL20250710025
Term of Validity
10 July 2025 - 10 July 2026
Company's Country
  • Poland
Type of partnership
  • Commercial agreement with technical assistance
  • Research and development cooperation agreement
Targeted Countries
  • All countries
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
A Polish biotech spin-off from the Warsaw University of Life Sciences (SGGW) has developed an innovative probiotic feed additive for poultry farming. The product features a newly isolated Paenibacillus strain with strong anti-Campylobacter activity, addressing a major zoonotic threat in the food supply chain. The company is seeking licensing partners, B2B distributors, and research collaborators.
Full Description
A spin-off company founded by scientists from three academic institutions, is developing a targeted probiotic solution for poultry farming. The product is based on a novel strain of Paenibacillus bacteria, isolated from wild plant seeds, which demonstrates high efficacy in inhibiting pathogenic Campylobacter jejuni and coli, as confirmed by in-vitro testing.

Campylobacteriosis remains the most common foodborne bacterial infection in Europe, causing ~9 million cases annually and costing the EU ~2.4 billion EUR. There is currently no probiotic on the market that effectively addresses this issue at the source — the poultry farm.

The innovation targets improved flock health, reduced antimicrobial resistance, and safer meat for consumers. ProHerd is currently finalizing its R&D phase (TRL 6–7) with secured funding and is actively seeking commercialization and co-development opportunities.
Advantages and Innovations
- First-of-its-kind probiotic with proven anti-Campylobacter effect;

- Isolated from natural sources; non-GMO and safe for feed use;

- Aligned with One Health goals – reduces human exposure to antibiotic-resistant bacteria;

- Supported by a multidisciplinary scientific team with expertise in microbiology, feed production, and bio-innovation;

- No direct competition offering strain-specific anti-pathogen functionality.
Stage of Development
  • Available for demonstration
Sustainable Development Goals
  • Goal 9: Industry, Innovation and Infrastructure
  • Goal 3: Good Health and Well-being
IPR status
  • Secret know-how

Partner Sought

Expected Role of a Partner
- Feed manufacturers seeking to license the technology and integrate it into their product lines;

- Poultry producers interested in implementing the product to improve farm biosecurity;

- Research institutions or industry partners seeking to collaborate on field trials, new formulations, or regulatory approval.
Type and Size of Partner
  • SME 50 - 249
  • R&D Institution
  • SME <=10
Type of partnership
  • Commercial agreement with technical assistance
  • Research and development cooperation agreement

Dissemination

Technology keywords
  • 06002006 - Synthetic Biology
  • 06002002 - Cellular and Molecular Biology
  • 06002005 - Genetic Engineering
  • 06002001 - Biochemistry / Biophysics
Market keywords
  • 04007 - Enzymology/Protein Engineering/Fermentation
  • 04008 - Genetic Engineering
  • 04005 - Biochemistry / Biophysics
Targeted countries
  • All countries